K2 Principal Fund’s Pasithea Therapeutics KTTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-14,122
| Closed | -$181K | – | 231 |
|
2022
Q4 | $181K | Sell |
14,122
-10,468
| -43% | -$134K | 0.03% | 88 |
|
2022
Q3 | $620K | Hold |
24,590
| – | – | 0.07% | 76 |
|
2022
Q2 | $497K | Sell |
24,590
-2,910
| -11% | -$58.8K | 0.05% | 122 |
|
2022
Q1 | $715K | Hold |
27,500
| – | – | 0.06% | 89 |
|
2021
Q4 | $973K | Buy |
+27,500
| New | +$973K | 0.06% | 127 |
|